Stock listing

NASDAQ:BRVE Braveheart Bio, Inc. Stock

Home listing (NASDAQ) of Braveheart Bio, Inc.

Follow Braveheart Bio, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:BRVE

$18.78 USD -0.71 (-3.6%)

Close on Nov 17, 2026

Past 3 months -37.0% · daily closes, Aug 6, 2026 – Nov 17, 2026, adjusted for splits
Day range
$17.79 – $19.46 USDNov 17, 2026
Volume
971,285 sharesNov 17, 2026
Market cap
$1.69B USDAt the close on Nov 17, 2026 · price × 90.04M shares outstanding
Traded on an average day
$10.37M USDMedian day 335,322 shares · last 3 months, Aug 17, 2026 – Nov 17, 2026

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BRVE · Home$18.78 USD-0.71 (-3.6%)971,285$19.46$19.46$17.79$19.49Close on Nov 17, 2026

Daily closes

Last 3 months, Aug 17, 2026 – Nov 17, 2026 · NASDAQ:BRVE · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$18.78-0.71-3.6%$19.46$19.46$17.79971,285
$19.49-0.13-0.7%$20.04$20.21$18.71725,376
$19.62-0.88-4.3%$20.41$20.41$19.19536,604
$20.50-0.40-1.9%$20.97$21.30$20.01256,070
$20.90+1.28+6.5%$20.04$21.85$19.41488,966
$19.62+0.16+0.8%$19.13$19.76$18.88211,466
$19.46+0.86+4.6%$19.08$19.87$18.61618,350
$18.60+1.185+6.8%$17.55$18.99$16.89702,051
$17.42-2.69-13.4%$19.84$19.84$16.701,590,097
$20.11-1.285-6.0%$21.54$21.56$19.16655,535
$21.39+0.35+1.7%$20.94$21.53$20.24305,539
$21.04-0.47-2.2%$21.79$21.79$20.51260,119
$21.51+0.32+1.5%$21.29$21.77$20.75533,666
$21.19-0.57-2.6%$21.55$22.20$20.62304,125
$21.76-0.06-0.3%$21.74$21.85$20.77246,219
$21.82-0.05-0.2%$22.00$22.22$21.38156,109
$21.87+0.43+2.0%$21.71$21.96$21.32101,220
$21.44-0.04-0.2%$21.45$21.53$20.58119,555
$21.48+0.44+2.1%$21.14$21.80$20.68156,502
$21.04+0.77+3.8%$20.64$21.36$19.67224,146
$20.27+1.06+5.5%$19.21$20.81$19.15323,870
$19.21+0.50+2.7%$18.72$19.42$18.15333,743
$18.71-0.84-4.3%$19.50$19.59$18.00414,900
$19.55+0.21+1.1%$19.54$20.13$19.18206,100
$19.34+0.01+0.1%$19.33$19.90$18.62462,800
$19.33-1.03-5.1%$20.44$20.56$19.04212,300
$20.36+0.34+1.7%$20.17$20.78$19.22155,100
$20.02+0.93+4.9%$18.91$20.24$18.44255,000
$19.09+0.51+2.7%$18.53$19.32$17.86389,200
$18.58-1.21-6.1%$19.61$19.65$18.47336,900
$19.79-1.56-7.3%$21.59$21.59$19.67590,300
$21.35+0.08+0.4%$21.57$22.02$19.83889,000
$21.27-0.14-0.7%$21.44$21.98$20.77462,800
$21.41+1.21+6.0%$19.90$22.36$19.88669,400
$20.20-2.14-9.6%$22.30$22.30$20.01967,500
$22.34+1.27+6.0%$21.00$22.51$20.37719,200
$21.07+0.45+2.2%$20.25$22.05$20.01389,300
$20.62-2.75-11.8%$23.58$23.86$20.53471,800
$23.37+1.91+8.9%$21.41$23.80$20.70396,700
$21.46-2.15-9.1%$23.21$23.77$21.31521,700
$23.61-1.41-5.6%$25.41$25.41$23.42829,400
$25.02-4.18-14.3%$28.90$28.90$24.631,570,800
$29.20+1.49+5.4%$27.78$29.50$27.472,017,800
$27.71+0.26+0.9%$27.76$28.90$27.16577,400
$27.45+0.74+2.8%$26.82$28.90$26.22550,700
$26.71-0.31-1.1%$26.95$27.98$26.31275,000
$27.02+0.38+1.4%$26.75$27.76$26.29209,200
$26.64-0.61-2.2%$28.12$28.74$26.54283,600
$27.25-1.66-5.7%$28.94$29.50$26.47286,000
$28.91-0.50-1.7%$29.13$29.97$27.93309,700
$29.41+2.67+10.0%$27.18$29.91$27.18613,200
$26.74+0.47+1.8%$25.81$27.48$25.39272,100
$26.27-0.68-2.5%$27.22$27.22$25.19327,600
$26.95+0.67+2.5%$26.53$27.78$25.69394,500
$26.28+0.78+3.1%$25.76$27.06$24.90342,900
$25.50-1.94-7.1%$27.95$27.95$24.31806,200
$27.44-0.42-1.5%$27.98$29.24$27.38162,500
$27.86+0.10+0.4%$27.50$29.00$27.50127,800
$27.76+0.12+0.4%$27.80$28.65$27.01215,200
$27.64+0.14+0.5%$28.29$29.25$27.07155,335
$27.50-0.08-0.3%$27.64$28.00$26.17101,993
$27.58+0.16+0.6%$27.49$28.10$27.12130,500
$27.42-1.55-5.4%$28.43$28.89$26.54176,200
$28.97+2.22+8.3%$26.99$30.12$26.86391,800
$26.75-0.91-3.3%$27.64$28.50$25.76215,000
$27.66+0.63+2.3%$26.97$28.29$26.67310,200
Ticker
NASDAQ:BRVE
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Braveheart Bio, Inc. news

Financings

  • Public offering of common stock

    Sep 8, 2026

    Closed: US$439.9M in the latest tranche · US$18 a share · Goldman Sachs & Co. LLC +4

    Dealers: Goldman Sachs & Co. LLC (co-lead), Jefferies (co-lead), TD Cowen (co-lead), Stifel (co-lead), Cantor (co-lead)

    Announced Aug 6, 2026 · Closed Aug 7, 2026 · Closed Sep 8, 2026

Read by 6ix AI from the company's releases

Decks

Braveheart Bio, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
10 in the last 12 months · 10 in all · newest Nov 10, 2026 · oldest 2026
Decks
2 decks · latest May 11, 2026

Where Braveheart Bio, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BRVE · Home listing · This pageNASDAQUnited StatesUSD
BOATS:BRVEBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Braveheart Bio, Inc.